Key TakeawaysThe MFN policy seeks to align US drug prices with international benchmarks, affecting company pricing strategies and behavior.Tariffs on foreign-manufactured drugs could increase patient costs, serving as a negotiation tool rather than a broad market application.Direct-to-consumer channels may disrupt traditional supply chains, challenging pharmacy benefit managers and potentially affecting insurance coverage.Linking MFN prices to […]
